Trial Profile
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcaemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Hypercalcaemia; Primary hyperparathyroidism
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 10 Jun 2014 New trial record